Inadequate last-mile pharmaceutical waste management is a neglected threat to environmental and public health: a call to action

Authors:
Open Access
Publisher website
Google Scholar
Abstract
In 2024, the WHO’s Division on Access to Medicines and Health Products issued a call to action for sustainability in the pharmaceutical sector. The initiative, ‘Greener Pharmaceuticals’ Regulatory Highway’, underscored the need to reduce the environmental footprint of medical products. It explicitly called on the regulatory community to adopt initiatives towards ‘innovative approaches in the manufacturing, distribution, and usage of medical products.’ 1 This timely initiative aligns with the growing recognition of interconnectedness between climate change, pollution—including ‘pharmaceutical pollution’—and public health. However, the need to decrease greenhouse gas emissions should not overshadow other relevant areas for action in the pharmaceutical sector. Here, we focus on the negative environmental impact of the inappropriate elimination of pharmaceutical waste generated at the last mile in healthcare.

This publication has 11 references indexed in Scilit: